Seeing Is Believing With This Blockbuster Eye Deal

Valeant Pharmaceuticals (NYSE: VRX  ) grows through acquisition, mostly through smaller accretive deals. But management had its elephant guns loaded and after missing out on generic drugmaker Actavis bagged its big game via an $8.7 billion buyout of eye-care heavyweight Bausch & Lomb.

In this video, health-care analyst David Williamson discusses why Valeant investors should be excited about adding Bausch & Lomb instead of Actavis and whether more transformative acquisitions are on the way.

Another topic health care investors need to keep up on is Obamacare, as the law will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more. 

Follow David on Twitter: @MotleyDavid.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2459279, ~/Articles/ArticleHandler.aspx, 4/24/2014 1:19:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

TREND TRACKER: Get Rich When the Web Goes Dark

It's time to say "goodbye" to your Internet! One bleeding-edge technology is about to put the World Wide Web to bed. And if you act right away, it could make you wildly rich. Experts are calling it the single largest business opportunity in the history of capitalism… The Economist is calling it "transformative"... but you'll probably just call it "how I made my millions." Big money is already on the move. Don't be too late to the party – find out the 1 stock to own when the Web goes dark.


Advertisement